Analysis of risk factors for cancer-specific survival in neoadjuvant chemotherapy nonresponsive disease of muscle-invasive bladder cancer: A multicentre study from the Turkish Urooncology Association Bladder Tumor study group

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTeke, Kerem
dc.contributor.authorYilmaz, Hasan
dc.contributor.authorBaltaci, Sumer
dc.contributor.authorAkgul, Murat
dc.contributor.authorTurkeri, Levent
dc.contributor.authorSahin, Bahadir
dc.contributor.authorBozkurt, Ozan
dc.contributor.authorYucetas, Ugur
dc.contributor.authorAslan, Guven
dc.contributor.authorBolat, Deniz
dc.contributor.authorIzol, Volkan
dc.contributor.authorOzkan, T. Alp
dc.contributor.authorEskicorapci, Saadettin
dc.contributor.authorTurkish Urooncol Assoc Bladder Tumor study Grp
dc.date.accessioned2025-10-16T15:12:24Z
dc.date.issued2025
dc.identifier.doi10.1016/j.urolonc.2024.09.006
dc.identifier.otherWOS:001369783500001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5420
dc.publisherELSEVIER SCIENCE INC
dc.sourceUROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
dc.subjectbladder cancer
dc.subjectmuscle\\-invasive bladder cancer
dc.subjectneoadjuvant chemotherapy
dc.subjectNAC
dc.subjectypN
dc.subjectNAC nonresponsive disease
dc.subjectnonresponse to NAC
dc.subjectcan\\- cer\\-specific survival
dc.titleAnalysis of risk factors for cancer-specific survival in neoadjuvant chemotherapy nonresponsive disease of muscle-invasive bladder cancer: A multicentre study from the Turkish Urooncology Association Bladder Tumor study group
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS